HOME / Notice / News / EN
NKCL Bio Group researches and develops NK cell therapeutics using the technology of culture method for autologous immune cells, which maintains the same quality of cell therapy products. We are leading the universalization of NK cell therapeutics by establishing a GMP automatic culture system that en...
NKCL Bio Group, exclusive license and its contents NKCL Bio Group has secured an exclusive license by signing a contract for a patent-exclusive license. Exclusive license refers to the right of the patentee, etc. to exclusively use the patented invention as a business within the scope of a contract w...
Last thirtieth of November, NKCL Bio Group Inc. won the ninth 2021 Future Creative Superiority Company Grand Award in the Innovative Immune Cell Cultivation Technology Field for the second time in a row. ‘Future Creative Superiority Company Grand Award’ is an award to discover and select companies ...
NKCL Bio Group Inc. (hereinafter ‘NKCL,’ Chairman Shin DongHwa) won Moneytoday 2021 Future Creative Superiority Company Grand Award in the Innovative Immune Cell Cultivation Technology Field for the second time in a row. The ‘Future Creative Superiority Company Grand Award’ was established to dis...
[NK Immune Water, prop sponsoring a new SBS Drama ‘Now, we are breaking up.’ A picture provided by NKCL Bio Group Inc.] NKCL Bio Group Inc. supported a new SBS emotional melodrama, ‘Now We Are Breaking up,’ first aired on last Friday the 12th in kind through NK Immune Water prop sponsorship. NK I...
